Trial | NCT00002069  Report issue

Official Title

A Study of DTC in Patients With AIDS and AIDS Related Complex

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    thiocarb ...

  • Study Participants

    None
To determine if ditiocarb sodium (sodium diethyldithiocarbamate; DTC) restores immune and host defense function; if DTC ameliorates the AIDS related complex (ARC) symptoms in patients with AIDS and ARC; if DTC prevents progression from ARC to AIDS or progression of AIDS; and if DTC prolongs survival in AIDS.
Study Started
Nov 02
1999
Last Update
Jun 24
2005
Estimate

Drug Ditiocarb sodium

Criteria 

Inclusion Criteria

Concurrent Medication:

Allowed:

Zidovudine (AZT).

Exclusion Criteria

Co-existing Condition:

Patients with the following are excluded:

Active opportunistic infection or progressive Kaposi's sarcoma (KS).
Dementia.
Lymphoma.

Concurrent Medication:

Excluded within 3 weeks of study entry:

Other experimental AIDS therapy.

Patients with the following are excluded:

Active opportunistic infection or progressive Kaposi's sarcoma (KS).

Patients must be either HIV seropositive or have AIDS or AIDS related complex (ARC) and have life expectancy of at least 6 months.
No Results Posted